Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response

Andres Perroud Herman; Maria Alasino Carlos; Jose Rico Maria; Ernesto Mainetti Leandro; Queralt Francisco; Maris Pezzotto Stella; Rosa Rozados Viviana; Graciela Scharovsky O.

首页> 外文期刊>Cancer chemotherapy and pharmacology. >Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response

【24h】

Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response

机译：低剂量节律化疗联合环磷酰胺和塞来昔布治疗的转移性乳腺癌患者：临床结果和反应生物标志物

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Preclinical results showing therapeutic effect and low toxicity of metronomic chemotherapy with cyclophosphamide (Cy) + celecoxib (Cel) for mammary tumors encouraged its translation to the clinic for treating advanced breast cancer patients (ABCP).

机译：临床前结果显示，环磷酰胺（Cy）+塞来昔布（Cel）进行节律性化疗对乳腺癌的治疗效果和低毒性，促使其转为临床治疗晚期乳腺癌患者（ABCP）。

著录项

来源
《Cancer chemotherapy and pharmacology.》 |2016年第2期|共10页
作者
Andres Perroud Herman; Maria Alasino Carlos; Jose Rico Maria; Ernesto Mainetti Leandro; Queralt Francisco; Maris Pezzotto Stella; Rosa Rozados Viviana; Graciela Scharovsky O.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
Angiogenesis; Biomarkers; Cyclophosphamide; Celecoxib; Metronomic chemotherapy;

机译：血管生成;生物标志物;环磷酰胺;塞来昔布;组学化疗;

相似文献

外文文献
中文文献
专利

1. Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response [J] . Andres Perroud Herman, Maria Alasino Carlos, Jose Rico Maria, Cancer chemotherapy and pharmacology. . 2016,第2期

机译：低剂量节律化疗联合环磷酰胺和塞来昔布治疗的转移性乳腺癌患者：临床结果和反应生物标志物
2. Explorative Analysis of Low-Dose Metronomic Chemotherapy with Cyclophosphamide and Methotrexate in a Cohort of Metastatic Breast Cancer Patients [J] . Krajnak S., Battista M., Brenner W., Breast care . 2018,第4期

机译：转移性乳腺癌患者队列中环磷酰胺和甲氨蝶呤小剂量节律化疗的探索性分析
3. Explorative Analysis of Low-Dose Metronomic Chemotherapy with Cyclophosphamide and Methotrexate in a Cohort of Metastatic Breast Cancer Patients [J] . Slavomir Krajnak, Marco Battista, Walburgis Brenner, Breast care . 2018,第4期

机译：转移乳腺癌患者群体中环磷酰胺和甲氨蝶呤的低剂量度量化疗的勘探分析
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Combining biomarkers and clinicopathologic factors for prediction of response to adjuvant chemotherapy for breast cancer: Cox model and Support Vector Machine (SVM) methods. [D] . Liu, Xudong. 2010

机译：结合生物标志物和临床病理因素预测乳腺癌对辅助化疗的反应：Cox模型和支持向量机（SVM）方法。
6. Low-dose metronomic chemotherapy with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit [O] . G Masci, A Losurdo, C Gandini, 2012

机译：口服环磷酰胺和甲氨蝶呤的小剂量基因组化学疗法在转移性乳腺癌中的应用：延长临床获益的病例报告
7. Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response [O] . Herman Andres Perroud, Carlos Maria Alasino, Maria Jose Rico, 2015

机译：转移性乳腺癌患者用环磷酰胺和Celecoxib治疗低剂量融合化疗：临床结果和反应生物标志物

Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅